Support of the metabolic response to burn injury

Severe burn causes metabolic disturbances that can last for a year after injury; persistent and profound catabolism hampers rehabilitative efforts and delays the meaningful return of individuals to society. The simplest, effective anabolic strategies for severe burn injuries are: early excision and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2004-06, Vol.363 (9424), p.1895-1902
Hauptverfasser: Herndon, David N, Tompkins, Ronald G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1902
container_issue 9424
container_start_page 1895
container_title The Lancet (British edition)
container_volume 363
creator Herndon, David N
Tompkins, Ronald G
description Severe burn causes metabolic disturbances that can last for a year after injury; persistent and profound catabolism hampers rehabilitative efforts and delays the meaningful return of individuals to society. The simplest, effective anabolic strategies for severe burn injuries are: early excision and grafting of the wound; prompt treatment of sepsis; maintenance of environmental temperature at 30–32°C; continuous feeding of a high carbohydrate, high protein diet, preferably by the enteral route; and early institution of vigorous and aerobic resistive exercise programmes. To further keep erosion of lean body mass to a minimum, administration of anabolic agents, recombinant human growth hormone, insulin, oxandrolone, or anticatabolic drugs such as propranolol are alternative approaches. Exogenous continuous low-dose insulin infusion, β blockade with propranolol, and use of the synthetic testosterone analogue oxandrolone are the most cost effective and least toxic pharmacological treatments to date.
doi_str_mv 10.1016/S0140-6736(04)16360-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2069926575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673604163605</els_id><sourcerecordid>649443091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-a47053538b4813796aa41681ffc3d2c44cb573d6d6191efca78156d81cbca0483</originalsourceid><addsrcrecordid>eNqF0M9L3EAUwPGhVOpq_ROUUCnUQ-x7O29-5CRlsVZY8GAL3obJZIJZdjPpTFLY_96sG9RL8TSXz7z3-DJ2inCJgPL7PSBBLhWX34AuUHIJufjAZkiKckHq4SObvZBDdpTSCgBIgvjEDlGg5pLDjMH90HUh9lmos_7RZxvf2zKsG5dFn7rQJp_1ISuH2GZNuxri9jM7qO06-ZPpPWZ_fl7_XvzKl3c3t4sfy9wJSX1uSYHgguuSNHJVSGsJpca6dryaOyJXCsUrWUks0NfOKo1CVhpd6SyQ5sfsfD-3i-Hv4FNvVmG8Ylxp5iCLYi6FEqP68j-FhS40CeIjEnvkYkgp-tp0sdnYuDUIZhfTPMc0u1IGyDzHNLvhZ9Pwodz46vXXVG8EXydgk7PrOtrWNemN04SqwNFd7Z0fg_1rfDTJNb51vmqid72pQvPOKU9L-I3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198984543</pqid></control><display><type>article</type><title>Support of the metabolic response to burn injury</title><source>MEDLINE</source><source>EBSCOhost Business Source Complete</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Herndon, David N ; Tompkins, Ronald G</creator><creatorcontrib>Herndon, David N ; Tompkins, Ronald G</creatorcontrib><description>Severe burn causes metabolic disturbances that can last for a year after injury; persistent and profound catabolism hampers rehabilitative efforts and delays the meaningful return of individuals to society. The simplest, effective anabolic strategies for severe burn injuries are: early excision and grafting of the wound; prompt treatment of sepsis; maintenance of environmental temperature at 30–32°C; continuous feeding of a high carbohydrate, high protein diet, preferably by the enteral route; and early institution of vigorous and aerobic resistive exercise programmes. To further keep erosion of lean body mass to a minimum, administration of anabolic agents, recombinant human growth hormone, insulin, oxandrolone, or anticatabolic drugs such as propranolol are alternative approaches. Exogenous continuous low-dose insulin infusion, β blockade with propranolol, and use of the synthetic testosterone analogue oxandrolone are the most cost effective and least toxic pharmacological treatments to date.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(04)16360-5</identifier><identifier>PMID: 15183630</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Body mass ; Burns ; Burns - metabolism ; Burns - therapy ; Calorimetry ; Carbohydrates ; Catabolism ; Drug therapy ; Energy ; Energy Metabolism ; Enteral nutrition ; Erosion resistance ; Fatty acids ; Feeding ; General aspects ; Growth hormones ; High carbohydrate diet ; High protein diet ; Hormones ; Hormones - therapeutic use ; Humans ; Immune response ; Infections ; Injuries ; Insulin ; Insulin resistance ; Lean body mass ; Medical sciences ; Medical treatment ; Metabolic response ; Metabolism ; Nutrition ; Nutritional Support ; Oxidation ; Oxidation-Reduction ; Oxygen Consumption ; Parenteral nutrition ; Pharmacology ; Plant-based beverages ; Propranolol ; Proteins ; Rehabilitation ; Sepsis ; Skin ; Skin &amp; tissue grafts ; Temperature ; Testosterone ; Traumas. Diseases due to physical agents</subject><ispartof>The Lancet (British edition), 2004-06, Vol.363 (9424), p.1895-1902</ispartof><rights>2004 Elsevier Ltd</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Jun 5, 2004</rights><rights>Copyright Elsevier Limited Jun 5, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-a47053538b4813796aa41681ffc3d2c44cb573d6d6191efca78156d81cbca0483</citedby><cites>FETCH-LOGICAL-c564t-a47053538b4813796aa41681ffc3d2c44cb573d6d6191efca78156d81cbca0483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/198984543?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993,64383,64387,72239</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15841791$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15183630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Herndon, David N</creatorcontrib><creatorcontrib>Tompkins, Ronald G</creatorcontrib><title>Support of the metabolic response to burn injury</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Severe burn causes metabolic disturbances that can last for a year after injury; persistent and profound catabolism hampers rehabilitative efforts and delays the meaningful return of individuals to society. The simplest, effective anabolic strategies for severe burn injuries are: early excision and grafting of the wound; prompt treatment of sepsis; maintenance of environmental temperature at 30–32°C; continuous feeding of a high carbohydrate, high protein diet, preferably by the enteral route; and early institution of vigorous and aerobic resistive exercise programmes. To further keep erosion of lean body mass to a minimum, administration of anabolic agents, recombinant human growth hormone, insulin, oxandrolone, or anticatabolic drugs such as propranolol are alternative approaches. Exogenous continuous low-dose insulin infusion, β blockade with propranolol, and use of the synthetic testosterone analogue oxandrolone are the most cost effective and least toxic pharmacological treatments to date.</description><subject>Biological and medical sciences</subject><subject>Body mass</subject><subject>Burns</subject><subject>Burns - metabolism</subject><subject>Burns - therapy</subject><subject>Calorimetry</subject><subject>Carbohydrates</subject><subject>Catabolism</subject><subject>Drug therapy</subject><subject>Energy</subject><subject>Energy Metabolism</subject><subject>Enteral nutrition</subject><subject>Erosion resistance</subject><subject>Fatty acids</subject><subject>Feeding</subject><subject>General aspects</subject><subject>Growth hormones</subject><subject>High carbohydrate diet</subject><subject>High protein diet</subject><subject>Hormones</subject><subject>Hormones - therapeutic use</subject><subject>Humans</subject><subject>Immune response</subject><subject>Infections</subject><subject>Injuries</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Lean body mass</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Metabolic response</subject><subject>Metabolism</subject><subject>Nutrition</subject><subject>Nutritional Support</subject><subject>Oxidation</subject><subject>Oxidation-Reduction</subject><subject>Oxygen Consumption</subject><subject>Parenteral nutrition</subject><subject>Pharmacology</subject><subject>Plant-based beverages</subject><subject>Propranolol</subject><subject>Proteins</subject><subject>Rehabilitation</subject><subject>Sepsis</subject><subject>Skin</subject><subject>Skin &amp; tissue grafts</subject><subject>Temperature</subject><subject>Testosterone</subject><subject>Traumas. Diseases due to physical agents</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqF0M9L3EAUwPGhVOpq_ROUUCnUQ-x7O29-5CRlsVZY8GAL3obJZIJZdjPpTFLY_96sG9RL8TSXz7z3-DJ2inCJgPL7PSBBLhWX34AuUHIJufjAZkiKckHq4SObvZBDdpTSCgBIgvjEDlGg5pLDjMH90HUh9lmos_7RZxvf2zKsG5dFn7rQJp_1ISuH2GZNuxri9jM7qO06-ZPpPWZ_fl7_XvzKl3c3t4sfy9wJSX1uSYHgguuSNHJVSGsJpca6dryaOyJXCsUrWUks0NfOKo1CVhpd6SyQ5sfsfD-3i-Hv4FNvVmG8Ylxp5iCLYi6FEqP68j-FhS40CeIjEnvkYkgp-tp0sdnYuDUIZhfTPMc0u1IGyDzHNLvhZ9Pwodz46vXXVG8EXydgk7PrOtrWNemN04SqwNFd7Z0fg_1rfDTJNb51vmqid72pQvPOKU9L-I3g</recordid><startdate>20040605</startdate><enddate>20040605</enddate><creator>Herndon, David N</creator><creator>Tompkins, Ronald G</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>PRINS</scope></search><sort><creationdate>20040605</creationdate><title>Support of the metabolic response to burn injury</title><author>Herndon, David N ; Tompkins, Ronald G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-a47053538b4813796aa41681ffc3d2c44cb573d6d6191efca78156d81cbca0483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biological and medical sciences</topic><topic>Body mass</topic><topic>Burns</topic><topic>Burns - metabolism</topic><topic>Burns - therapy</topic><topic>Calorimetry</topic><topic>Carbohydrates</topic><topic>Catabolism</topic><topic>Drug therapy</topic><topic>Energy</topic><topic>Energy Metabolism</topic><topic>Enteral nutrition</topic><topic>Erosion resistance</topic><topic>Fatty acids</topic><topic>Feeding</topic><topic>General aspects</topic><topic>Growth hormones</topic><topic>High carbohydrate diet</topic><topic>High protein diet</topic><topic>Hormones</topic><topic>Hormones - therapeutic use</topic><topic>Humans</topic><topic>Immune response</topic><topic>Infections</topic><topic>Injuries</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Lean body mass</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Metabolic response</topic><topic>Metabolism</topic><topic>Nutrition</topic><topic>Nutritional Support</topic><topic>Oxidation</topic><topic>Oxidation-Reduction</topic><topic>Oxygen Consumption</topic><topic>Parenteral nutrition</topic><topic>Pharmacology</topic><topic>Plant-based beverages</topic><topic>Propranolol</topic><topic>Proteins</topic><topic>Rehabilitation</topic><topic>Sepsis</topic><topic>Skin</topic><topic>Skin &amp; tissue grafts</topic><topic>Temperature</topic><topic>Testosterone</topic><topic>Traumas. Diseases due to physical agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herndon, David N</creatorcontrib><creatorcontrib>Tompkins, Ronald G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>ProQuest Central China</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herndon, David N</au><au>Tompkins, Ronald G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Support of the metabolic response to burn injury</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2004-06-05</date><risdate>2004</risdate><volume>363</volume><issue>9424</issue><spage>1895</spage><epage>1902</epage><pages>1895-1902</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Severe burn causes metabolic disturbances that can last for a year after injury; persistent and profound catabolism hampers rehabilitative efforts and delays the meaningful return of individuals to society. The simplest, effective anabolic strategies for severe burn injuries are: early excision and grafting of the wound; prompt treatment of sepsis; maintenance of environmental temperature at 30–32°C; continuous feeding of a high carbohydrate, high protein diet, preferably by the enteral route; and early institution of vigorous and aerobic resistive exercise programmes. To further keep erosion of lean body mass to a minimum, administration of anabolic agents, recombinant human growth hormone, insulin, oxandrolone, or anticatabolic drugs such as propranolol are alternative approaches. Exogenous continuous low-dose insulin infusion, β blockade with propranolol, and use of the synthetic testosterone analogue oxandrolone are the most cost effective and least toxic pharmacological treatments to date.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>15183630</pmid><doi>10.1016/S0140-6736(04)16360-5</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2004-06, Vol.363 (9424), p.1895-1902
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_journals_2069926575
source MEDLINE; EBSCOhost Business Source Complete; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects Biological and medical sciences
Body mass
Burns
Burns - metabolism
Burns - therapy
Calorimetry
Carbohydrates
Catabolism
Drug therapy
Energy
Energy Metabolism
Enteral nutrition
Erosion resistance
Fatty acids
Feeding
General aspects
Growth hormones
High carbohydrate diet
High protein diet
Hormones
Hormones - therapeutic use
Humans
Immune response
Infections
Injuries
Insulin
Insulin resistance
Lean body mass
Medical sciences
Medical treatment
Metabolic response
Metabolism
Nutrition
Nutritional Support
Oxidation
Oxidation-Reduction
Oxygen Consumption
Parenteral nutrition
Pharmacology
Plant-based beverages
Propranolol
Proteins
Rehabilitation
Sepsis
Skin
Skin & tissue grafts
Temperature
Testosterone
Traumas. Diseases due to physical agents
title Support of the metabolic response to burn injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T04%3A08%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Support%20of%20the%20metabolic%20response%20to%20burn%20injury&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Herndon,%20David%20N&rft.date=2004-06-05&rft.volume=363&rft.issue=9424&rft.spage=1895&rft.epage=1902&rft.pages=1895-1902&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(04)16360-5&rft_dat=%3Cproquest_cross%3E649443091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198984543&rft_id=info:pmid/15183630&rft_els_id=S0140673604163605&rfr_iscdi=true